checkAd
    Startseite > Aktien > CymaBay Therapeutics > Nachrichten
    CymaBay Therapeutics
    Aktie
    ISIN: US23257D1037 WKN: A116DD SYM: CBAY Land USA
    Zur Watchlist hinzufügen Zum Portfolio hinzufügen
    32,48
     
    USD
    +0,03 %
    +0,01 USD
    Letzter Kurs 22.03.24 NYSE
    Geldkurs
    21.03.24
    32,43
     
    USD
    200 STK
    Briefkurs
    21.03.24
    32,49
     
    USD
    33.300 STK

    CymaBay Therapeutics Aktie kaufen

    Kauf
    Verkauf

    Neueste Nachrichten

    Gilead Sciences Announces Completion of Acquisition of CymaBay
    22.03.24 · Business Wire (engl.) · Gilead Sciences
    Fokus Aktien mit extremen Handelsvolumen am Montag, den 04.03.2024
    04.03.24 · wO Chartvergleich · Myriad Genetics
    CymaBay Announces European Medicines Agency Accepts for Review the Marketing Authorization Application for Seladelpar for the Treatment of Primary Biliary Cholangitis
    04.03.24 · globenewswire · CymaBay Therapeutics
    CymaBay Reports Fourth Quarter and Year Ended December 31, 2023 Financial Results and Provides Corporate Update
    28.02.24 · globenewswire · CymaBay Therapeutics
    CymaBay Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
    20.02.24 · globenewswire · CymaBay Therapeutics
    CYMABAY THERAPEUTICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of CymaBay Therapeutics, Inc. - CBAY
    16.02.24 · Business Wire (engl.) · CymaBay Therapeutics
    Biotech-Übernahme: US-Biotechkonzern Gilead kauft Konkurrenten CymaBay in Milliarden-Deal
    12.02.24 · wallstreetONLINE Redaktion · Gilead Sciences
    CBAY Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of CymaBay Therapeutics, Inc. Is Fair to Shareholders
    12.02.24 · Business Wire (engl.) · CymaBay Therapeutics
    Gilead Sciences Expands Liver Portfolio With Acquisition of CymaBay Therapeutics
    12.02.24 · Business Wire (engl.) · Gilead Sciences
    CymaBay Therapeutics to Participate in Upcoming Investment Conferences
    31.01.24 · globenewswire · CymaBay Therapeutics
    CymaBay Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
    16.01.24 · globenewswire · CymaBay Therapeutics
    CymaBay Therapeutics to Present at the 42nd Annual JP Morgan Healthcare Conference 2024
    02.01.24 · globenewswire · CymaBay Therapeutics